vs
Side-by-side financial comparison of Dragonfly Energy Holdings Corp. (DFLI) and Immunovant, Inc. (IMVT). Click either name above to swap in a different company.
Dragonfly Energy Holdings Corp. is the larger business by last-quarter revenue ($13.1M vs $8.4M, roughly 1.6× Immunovant, Inc.). Dragonfly Energy Holdings Corp. runs the higher net margin — -344.9% vs -899.0%, a 554.1% gap on every dollar of revenue. On growth, Immunovant, Inc. posted the faster year-over-year revenue change (140.7% vs 6.9%). Dragonfly Energy Holdings Corp. produced more free cash flow last quarter ($-14.9M vs $-59.8M).
Dragonfly Energy Holdings Corp. is a U.S.-based energy technology company specializing in designing and manufacturing high-performance, sustainable lithium-ion batteries. Its core offerings include deep-cycle batteries for RVs, marine uses, off-grid power systems, and residential energy storage, primarily serving consumer and small industrial renewable energy markets across North America.
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative monoclonal antibody therapies for patients with serious, rare autoimmune and inflammatory diseases. Its lead product candidate covers multiple autoimmune indications, with core U.S. operations and a global market expansion strategy.
DFLI vs IMVT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $13.1M | $8.4M |
| Net Profit | $-45.0M | $-75.3M |
| Gross Margin | 18.2% | — |
| Operating Margin | -78.1% | -896.2% |
| Net Margin | -344.9% | -899.0% |
| Revenue YoY | 6.9% | 140.7% |
| Net Profit YoY | -357.6% | -26.7% |
| EPS (diluted) | $-13.09 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.1M | — | ||
| Q3 25 | $16.0M | — | ||
| Q2 25 | $16.2M | — | ||
| Q1 25 | $13.4M | — | ||
| Q4 24 | $12.2M | — | ||
| Q3 24 | $12.7M | — | ||
| Q2 24 | $13.2M | — | ||
| Q1 24 | $12.5M | $8.4M |
| Q4 25 | $-45.0M | — | ||
| Q3 25 | $-11.1M | — | ||
| Q2 25 | $-7.0M | — | ||
| Q1 25 | $-6.8M | — | ||
| Q4 24 | $-9.8M | — | ||
| Q3 24 | $-6.8M | — | ||
| Q2 24 | $-13.6M | — | ||
| Q1 24 | $-10.4M | $-75.3M |
| Q4 25 | 18.2% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 28.3% | — | ||
| Q1 25 | 29.4% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 22.6% | — | ||
| Q2 24 | 24.0% | — | ||
| Q1 24 | 24.4% | — |
| Q4 25 | -78.1% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -20.2% | — | ||
| Q1 25 | -44.3% | — | ||
| Q4 24 | -58.5% | — | ||
| Q3 24 | -47.4% | — | ||
| Q2 24 | -51.1% | — | ||
| Q1 24 | -46.7% | -896.2% |
| Q4 25 | -344.9% | — | ||
| Q3 25 | -69.3% | — | ||
| Q2 25 | -43.3% | — | ||
| Q1 25 | -50.9% | — | ||
| Q4 24 | -80.6% | — | ||
| Q3 24 | -53.3% | — | ||
| Q2 24 | -103.2% | — | ||
| Q1 24 | -82.9% | -899.0% |
| Q4 25 | $-13.09 | — | ||
| Q3 25 | $-0.20 | — | ||
| Q2 25 | $-0.58 | — | ||
| Q1 25 | $-0.93 | — | ||
| Q4 24 | $-54.60 | — | ||
| Q3 24 | $-0.11 | — | ||
| Q2 24 | $-0.22 | — | ||
| Q1 24 | $-0.17 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.3M | $635.4M |
| Total DebtLower is stronger | $19.3M | — |
| Stockholders' EquityBook value | $11.5M | $617.8M |
| Total Assets | $86.5M | $666.4M |
| Debt / EquityLower = less leverage | 1.68× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.3M | — | ||
| Q3 25 | $3.8M | — | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $4.8M | — | ||
| Q3 24 | $8.0M | — | ||
| Q2 24 | $4.7M | — | ||
| Q1 24 | $8.5M | $635.4M |
| Q4 25 | $19.3M | — | ||
| Q3 25 | $97.1M | — | ||
| Q2 25 | $93.2M | — | ||
| Q1 25 | $89.5M | — | ||
| Q4 24 | $85.9M | — | ||
| Q3 24 | $82.4M | — | ||
| Q2 24 | $80.4M | — | ||
| Q1 24 | $77.1M | — |
| Q4 25 | $11.5M | — | ||
| Q3 25 | $-21.6M | — | ||
| Q2 25 | $-16.6M | — | ||
| Q1 25 | $-15.6M | — | ||
| Q4 24 | $-9.4M | — | ||
| Q3 24 | $-297.0K | — | ||
| Q2 24 | $5.3M | — | ||
| Q1 24 | $17.8M | $617.8M |
| Q4 25 | $86.5M | — | ||
| Q3 25 | $73.8M | — | ||
| Q2 25 | $71.8M | — | ||
| Q1 25 | $74.2M | — | ||
| Q4 24 | $75.2M | — | ||
| Q3 24 | $83.9M | — | ||
| Q2 24 | $85.0M | — | ||
| Q1 24 | $88.4M | $666.4M |
| Q4 25 | 1.68× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 15.27× | — | ||
| Q1 24 | 4.33× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.7M | $-59.7M |
| Free Cash FlowOCF − Capex | $-14.9M | $-59.8M |
| FCF MarginFCF / Revenue | -113.8% | -714.4% |
| Capex IntensityCapex / Revenue | 1.1% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-214.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-14.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.5M | — | ||
| Q4 24 | $-2.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-3.4M | $-59.7M |
| Q4 25 | $-14.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-5.3M | — | ||
| Q4 24 | $-3.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-4.2M | $-59.8M |
| Q4 25 | -113.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -39.6% | — | ||
| Q4 24 | -28.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -33.7% | -714.4% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.5% | 1.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DFLI
| Original Equipment Manufacturers | $8.1M | 62% |
| Sales Channel Directly To Consumer | $4.7M | 36% |
IMVT
Segment breakdown not available.
